Zobrazeno 1 - 10
of 16
pro vyhledávání: '"María Jesús Moro"'
Autor:
María Jesús MORO ALMARAZ
Publikováno v:
Ars Iuris Salmanticensis, Vol 2, Iss 1, Pp 11-16 (2014)
Externí odkaz:
https://doaj.org/article/7afc21d1d83c4dd69e7e84ff6867c4d0
Autor:
J.A. Blázquez Cabrera, M. Sosa Henriquez, M. Diaz-Curiel, P. Sánchez Molini, F. Arranz Garcia, M.J. Montoya, J. Filgueira, J.M. Olmos, M.B. Coco-Martín, J.L. Pérez Castrillón, María José Amerigo, Amalia Navarro, María Jesús Moro, José María Aguado Caballero, Dolors Armengol Sucarrats, María Luz Calero Bernal, Juan Carlos Cobeta, Rafael Cotos Canca, Begoña de Escalante Yanguas, Nerea Hernández de Sosa, José Luis Hernández, Julia Jareño Chaumel, M. Ángeles Vázquez Gómez, M. José Miranda García, Mercedes Giner García, Cristina Miranda Díaz, Antonio Pascual Vergara, Francisco Javier Rodero Hernández, Raimundo Tirado Miranda
Publikováno v:
Revista Clínica Española. 221:9-17
Resumen Antecedentes y objetivo La osteoporosis se considera un trastorno generalizado del esqueleto en el que existe una alteracion de la resistencia osea que predispone a la persona a un mayor riesgo de fractura. Este estudio transversal pretende r
Autor:
María Jesús Moro Álvarez, Rosa Arboiro Pinel, Concha de la Piedra Gordo, Daniel Blanes Jacquart, Manuel Diaz Curiel, Celia Rodríguez-Olleros Rodríguez
Publikováno v:
Journal of Orthopaedic Science. 25:715-718
Background The aim of the present study is to evaluate long term biochemical response to a single dose of zoledronic acid in patients with Paget disease of bone, as well as evaluating the value of bone turnover markers in diagnosis and follow-up. Met
Autor:
Carles Roig, Joan Molet, Rodrigo Rodríguez, Marina Guasch, María Jesús Moro Álvarez, Robert Belvis
Publikováno v:
Medicina Clínica. 154:75-79
Resumen Antecedentes y objetivo La cefalea en racimos (CR) es la cefalea humana mas grave y se cronifica en un 10-20% de los pacientes, pudiendo llegar a ser refractaria a todos los farmacos eficaces en un 10% de ellos. En este escenario se indican p
Autor:
Carles Roig, María Jesús Moro Álvarez, Robert Belvis, Marina Guasch, Rodrigo Rodríguez, Joan Molet
Publikováno v:
Medicina clinica. 154(3)
Background and objectives Cluster headache (CR) is the most severe human headache and is chronic in 10%–20% of patients, and 10% can become refractory to all effective drugs. In this scenario, surgical procedures are indicated: radiofrequencies of
Vacaciones terapéuticas en osteoporosis: estrategia en el tratamiento a largo plazo con bifosfonatos
Publikováno v:
Medicina Clínica. 146:24-29
Oral bisphosphonates (BF) are drugs widely used in the treatment of osteoporosis and placed as first-line treatment for osteoporosis in most clinical guidelines. BF are effective drugs that reduce the incidence of fractures and even reduce mortality.
Publikováno v:
Medicina Clínica (English Edition). 146:24-29
Oral bisphosphonates (BF) are drugs widely used in the treatment of osteoporosis and placed as first-line treatment for osteoporosis in most clinical guidelines. BF are effective drugs that reduce the incidence of fractures and even reduce mortality.
Autor:
Josep Blanch, L. Canals, María Jesús Moro, Javier del Pino-Montes, Luis Lizán, Xavier Nogués, María del Carmen Valero
Publikováno v:
Advances in therapy. 33(4)
The management of postmenopausal osteoporosis (PMO) in routine clinical practice differs considerably from guideline recommendations. The objective of our study was to reach a consensus on the management of PMO, considering prevention, diagnosis, tre
Publikováno v:
Revista Española de Geriatría y Gerontología. 45:141-149
Osteoporosis is a progressive skeletal disease characterized by a decrease in bone strength and an increase in the number of fractures. This disease is considered by the World Health Organization to be the second most important health problem in the
Publikováno v:
Clinical Interventions in Aging
Postmenopausal osteoporosis increases susceptibility to low-trauma fractures due to reduced bone volume and microarchitectural deterioration. Daily nitrogen-containing bisphosphonates have shown antifracture efficacy in many studies and are the most